Cosmetic Injections: The Untold Risks

Why the conversation about risk matters

When something is performed thousands of times each day, it can begin to feel routine. But routine and without risk are not the same thing. This is where many patients can feel caught between wanting treatment and not fully understanding what they are consenting to.

A well run consultation should leave you feeling informed, not reassured through omission.

Risks that are easy to overlook

Some risks are widely discussed, bruising, swelling, asymmetry. Others are less often raised:

• Vascular occlusion, a rare but serious complication where volume treatment enters or compresses a blood vessel
• Delayed inflammatory reactions, sometimes months or years after treatment
• Volume treatment accumulation over multiple sessions creating an unnatural appearance
• Infection, particularly when treatment is performed in non clinical environments
• Tyndall effect with certain products placed too superficially

What a safer consultation should include

A thorough consultation should include a review of your medical history, contraindications, current medications, and previous treatments. Questions worth asking: What are the specific risks for this treatment in this area? Do you carry hyaluronidase on site? How would a vascular event be managed?

Red flags when choosing a clinic

Signs that the risk conversation may be incomplete: no medical history review before treatment; pressure to book on the day; vague answers about complications; no clear informed consent process.

No ethical clinic can claim a particular result or a complication free experience. If those claims are made, that is a red flag, not a reassurance.

How to think about benefit versus risk

Risk in aesthetic treatments is real and variable. For most people, appropriately chosen treatment performed by a skilled and registered practitioner carries a low risk of serious complications. But low risk is not zero risk, and that distinction matters for informed consent.

About This Information

The information on this page is provided for general educational purposes. It is not a substitute for clinical advice and does not constitute a recommendation that you proceed with any particular treatment. Aesthetic treatments are prescription medical procedures. They carry risks that vary between individuals and that must be assessed and discussed in a clinical context before any treatment decision is made.

At Core Aesthetics, Corey Anderson assesses every patient individually. The consultation is the point at which your specific anatomy, medical history, and goals are evaluated together. No treatment is offered at a first appointment, and no treatment is appropriate for everyone. This page is a starting point, a way to understand what is involved before you decide whether a consultation is the right next step for you.

If you have questions about anything on this page or about whether treatment might be appropriate for your situation, you are welcome to call the clinic or book a consultation at no obligation.

This page provides clinical information about Cosmetic Injections: What the Risk Conversation Should Cover. It is intended for adults aged 18 and over who are considering aesthetic treatment and want to understand the clinical process, suitability factors, and what to expect from a consultation based practice. All treatment decisions at Core Aesthetics follow individual assessment, no treatment is offered at a first appointment without a separate consultation. Results vary between individuals and are reviewed at follow up.

The Role of Anatomical Assessment in Treatment Planning

Effective aesthetic treatment begins with understanding individual facial anatomy. The same concern, loss of cheek volume, for example, may have different underlying structural drivers in different people. In one patient it reflects fat pad atrophy; in another it involves bony remodelling; in a third, skin laxity changes the way existing volume appears. These distinctions affect both whether treatment is appropriate and, if so, how it should be approached.

At Core Aesthetics, the consultation begins with a systematic assessment of facial structure, including symmetry analysis, skin quality assessment, treatment history review, and discussion of the patient’s specific goals. This anatomical baseline informs every treatment decision and helps ensure that proposed treatments address the actual underlying driver of a concern rather than a surface level presentation.

This is one of the reasons Core Aesthetics operates as a one practitioner clinic with a consultation based model. A consistent clinical relationship between patient and practitioner supports the kind of longitudinal assessment that is difficult to achieve in high volume, multi practitioner settings.

Vascular Complications: The Most Serious Risk Category

Among the risks associated with aesthetic treatments, vascular complications represent the most serious category. These occur when volume treatment is inadvertently introduced into a blood vessel, either by direct injection or by external compression of a vessel. The consequence depends on the vessel affected and the speed of recognition and management.

Arterial occlusion, where volume treatment blocks arterial blood supply to a region, is a rare but genuine emergency. In severe cases, it can lead to tissue necrosis (tissue death) in the affected area. In even rarer cases involving vessels connected to the retinal circulation, it can cause vision loss. Published case literature documents these outcomes occurring in the hands of experienced practitioners as well as inexperienced ones, which is why the risk cannot be fully eliminated through skill alone.

The risk of vascular complications is managed through several complementary strategies: detailed knowledge of vascular anatomy in the face, careful injection technique including aspiration and use of cannulas where appropriate, use of small volumes at any single injection point, immediate recognition of warning signs (blanching, pain, mottling), and access to hyaluronidase for emergency dissolution of hyaluronic acid volume treatment.

At Core Aesthetics, Corey Anderson maintains training in vascular complication recognition and management, and keeps appropriate emergency medications on site. However, patients are informed during consultation that no practitioner or technique fully eliminates this risk, and that their willingness to accept this as part of their informed consent is a prerequisite for proceeding.

Delayed Inflammatory Reactions: A Less-Discussed Risk

Late onset inflammatory reactions to facial volume treatment, typically occurring weeks to months after treatment, represent a risk category that receives less attention than acute complications but causes significant distress when they occur. These reactions can present as firm nodules at injection sites, diffuse swelling, warmth, and in some cases pain.

The mechanism is not fully understood but appears to involve a delayed immune response to the volume treatment material. They can be triggered by systemic illnesses, dental procedures, and vaccinations in people who have hyaluronic acid volume treatment present in their tissues. The reaction is not an allergy in the conventional sense but a biofilm associated or immune mediated response to foreign material.

Management typically involves a combination of oral antibiotics, anti inflammatory medications, and in many cases hyaluronidase to dissolve the volume treatment and reduce the antigenic load. Most late onset inflammatory reactions resolve with appropriate management, but the process can take weeks to months and may cause temporary cosmetic disruption.

Patients at Core Aesthetics are informed of this risk as part of the pretreatment consultation, particularly those with a history of autoimmune conditions or those planning dental work or other procedures that carry infection risk in the post treatment period. This information is part of the informed consent process required under AHPRA’s September 2025 guidelines for nonsurgical cosmetic procedures.

Psychological Factors in Aesthetic treatment Decision-Making

The decision to pursue aesthetic treatment has a significant psychological dimension that is sometimes underweighted in risk discussions. The relationship between cosmetic treatment and self image is complex, and for some people treatment can become a pattern driven by body image concerns that injectable treatment does not address and may reinforce.

AHPRA’s September 2025 guidelines for nonsurgical cosmetic procedures explicitly address this. Registered practitioners are required to screen for signs of body dysmorphic disorder and other psychological factors indicating treatment is not appropriate, and to decline where these factors are present.

Body dysmorphic disorder involves preoccupation with perceived flaws that others do not observe or consider minor. Patients with this condition may pursue treatment repetitively and may never experience lasting satisfaction with results, because the driver of their distress is psychological rather than structural. Injectable treatment in this context does not help and may cause harm by reinforcing the belief that the perceived flaw is both real and correctable.

At Core Aesthetics, treatment motivation and treatment history form part of the standard clinical assessment. Where there are concerns about psychological factors, Corey Anderson will discuss this directly and, where appropriate, will decline to proceed and discuss alternative support options. This is part of responsible clinical practice under the AHPRA framework.

The Risk of Undertreated or Asymmetric Outcomes

Not all aesthetic treatment complications involve acute physical harm. A significant category of poor outcomes involves results that are technically safe but aesthetically unsatisfactory, overtreated areas that look unnatural, undertreated areas that were not addressed proportionally, or asymmetric results where one side of the face responded differently to treatment than the other.

These outcomes are difficult to define as complications in a clinical sense because there is no standard of what any face should look like. But they cause real distress for patients and they are more common than is often acknowledged. The injectable medicine literature documents significant rates of patient dissatisfaction even in cases where no acute adverse event occurred.

The factors that increase risk of these outcomes include: inadequate assessment before treatment; treatment performed on the same day as consultation without adequate time for reflection; practitioners who use standardised injection protocols without adapting to individual anatomy; and patients who come with unrealistic expectations about what injectable treatment can achieve.

Managing this risk requires the same clinical rigour as managing acute complication risk. At Core Aesthetics, every treatment plan is developed from individual assessment, discussed with the patient before any injection is made, and reviewed at a follow up appointment where the integrated outcome can be evaluated. The goal is not an aesthetic ideal but a result that achieves what was discussed and consented to.

The Regulatory Framework That Governs Risk Disclosure in Australia

In Australia, the advertising and clinical practice of aesthetic treatments is regulated by two overlapping frameworks: the Therapeutic Goods Administration (TGA) under the Therapeutic Goods Advertising Code, and the Australian Health Practitioner Regulation Agency (AHPRA) under its September 2025 cosmetic procedures guidelines. Understanding how these frameworks approach risk disclosure helps patients make sense of what practitioners are required to tell them, and what falls short of that standard.

The TGA Advertising Code prohibits aesthetic treatment advertising that implies safety through omission. If a practitioner advertises wrinkle injections without any reference to the fact that these are Schedule 4 prescription medicines with known adverse effects, that advertisement may breach the Code. Similarly, AHPRA’s guidelines require that patients be informed about realistic treatment outcomes, known complications, and the limits of what injectable treatment can achieve, all prior to any treatment taking place.

These requirements exist precisely because the risk profile of aesthetic treatments is meaningful. Bruising, swelling, asymmetry, and vascular complications are not theoretical, they occur at documented rates, and patients are entitled to weigh those rates when deciding whether to proceed. A practitioner who downplays or omits these risks during a consultation may be satisfying the aesthetic demand of the moment while failing their professional and legal obligations.

At Core Aesthetics, the consultation process is designed around informed consent as a genuine clinical process, not a form to sign before treatment begins. Corey Anderson, registered nurse and the sole practitioner, discusses known risks, likelihood, individual patient risk factors, and what to do in the event of a complication, before any decision is made about proceeding with treatment.

Patient Due Diligence: Reducing Your Own Risk Exposure

While practitioners carry the primary responsibility for safe treatment delivery, patients who approach aesthetic treatments with active due diligence are better positioned to avoid poor outcomes. This does not mean that complications are the patient’s fault, it means that patients who understand what to look for, what to ask, and what warning signs to heed are meaningfully safer than those who rely entirely on the practitioner’s professionalism.

Before any appointment, it is reasonable to ask the practitioner directly about their qualifications, their AHPRA registration status, and how they handle complications if they occur. A practitioner who is uncomfortable with any of these questions is communicating something important. AHPRA’s public register allows anyone to verify a practitioner’s registration and any conditions or reprimands on their record. This takes under two minutes and is worth doing.

On the day of treatment, patients should be alert to any consultation that feels rushed, any pressure to proceed immediately, or any framing that minimises downside risk. Legitimate practitioners welcome questions and take time with the consent process. They do not schedule treatment in the same appointment as a first consultation unless they have already conducted a thorough prior assessment. AHPRA’s September 2025 guidelines specifically address the cooling off period requirement and the separation of consultation from treatment in non emergency cosmetic procedures.

After treatment, knowing the difference between expected recovery signs and genuine warning signs is important. Some bruising, swelling, and tenderness is normal and resolves within days to two weeks. Pain that worsens after 48 hours, visual changes, skin blanching, or unusual firm lumps under the skin are not normal and warrant prompt contact with the treating practitioner or, if unavailable, a medical professional experienced in injectable complications. The faster a vascular complication is identified and treated, the better the outcome, delay significantly worsens prognosis in the rare but serious cases where it occurs.

Clinical accountability and how this page is reviewed

The clinical content in “Cosmetic Injections: What the Risk Conversation Should Cover” is written and reviewed by Corey Anderson, AHPRA registered nurse (NMW0001047575). Core Aesthetics operates as a one practitioner, consultation based, low volume clinic in Oakleigh, Melbourne, which means every recommendation on this page reflects the same clinical perspective rather than a copywriter’s interpretation of it. Results vary between individuals, and any guidance written for the general reader has to acknowledge that variance, what the published evidence supports for the average patient may not be what the assessment supports for a specific patient.

Specific to cosmetic injection risks: this page describes the typical clinical picture for a healthy adult patient at the time of writing. Individual circumstances, medical history, current medications, prior cosmetic treatment, skin type, age, hormonal state, lifestyle, can shift any of the timelines and recommendations described here. The information is provided to help patients arrive at consultation already familiar with the underlying clinical reasoning, not to replace the consultation itself. Results vary between individuals; this page describes the centre of the distribution, not the edges. The masseter treatment Melbourne page covers an adjacent topic in more depth.

Patients reading this page who want to verify Corey Anderson’s AHPRA registration can do so directly on the AHPRA public register at ahpra.gov.au using registration number NMW0001047575. The Core Aesthetics clinic operates from 12A Atherton Road, Oakleigh VIC 3166, Tuesday to Saturday, by consultation appointment. All new patient treatment at Core Aesthetics follows a structured clinical consultation, consistent with the September 2025 AHPRA cosmetic procedures guidelines. Treatment may be scheduled for the same day as consultation or at a subsequent appointment, depending on clinical assessment and individual circumstances. Patients with questions about the content on this page can raise them at consultation; the practitioner is happy to walk through any clinical reasoning that the written content does not fully capture. Results vary between individuals, and the consultation is the appropriate place to discuss what those individual variations mean for a specific person’s treatment plan.

One closing point worth making: the content on this page is intended to inform the consultation rather than replace it. Patients arrive at consultation with different baseline knowledge, different goals, and different prior experiences with cosmetic treatment, and the consultation is calibrated to the individual rather than to the average reader of this page. The written content does its job if it helps the patient ask better questions and understand the answers they receive. Patients researching the topic in more depth may find the consultation guide Melbourne page and the volume treatment bruising timeline page useful as further reading; both are written and reviewed under the same clinical accountability framework as this page.